PMID: 42199811

Efficacy and Safety of Telmisartan 20 mg/S-Amlodipine 2.5 mg versus Telmisartan 40 mg in Patients with Hypertension, Inadequately Controlled on Telmisartan 20 mg Monotherapy: A Randomized, Double-Blind, Multicenter, Phase 3 Trial.

Youn Jong-Chan, Kim Eui-Soon, Park Tae Ho, Lee Young Soo, Hong Soon Jun, Hwang Jin-Yong, Han Jung-Kyu, Son Jung-Woo, Lee Chan Joo, Choi Jung Hyun

Drug design, development and therapy · 2026

Vol. 20, pp. 587488

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansTelmisartanDouble-Blind MethodAmlodipineFemaleMaleHypertensionAntihypertensive AgentsMiddle AgedBlood Pressure

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.